About Tamim Al-Thani
Form D filings for Morphoceuticals in 2024 list Tamim Al-Thani as director.
Tamim Al-Thani first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Tamim Al-Thani in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Tamim Al-Thani works with at each company, as listed on that company's latest Form D.
Morphoceuticals, Inc. · Form D, Oct 7, 2024
MH
Michael Hufford
Director
AP
Alexander Pickett
Director
JB
Justin Briggs
Director
RH
Rosemarie Hunziker
Director
JJ
James Jenson
Chief Executive Officer and director